Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease - Cobo-Calvo, Alvaro; Sepúlveda, María; Rollot, Fabien; Armangué, Thais; Ruiz, Anne; Maillart, Elisabeth; Papeix, Caroline; Audoin, Bertrand; Zephir, Helene; Biotti, Damien; Ciron, Jonathan; Durand-Dubief, Francoise; et al. (Journal of neuroinflammation, 2019)
Keywords: Adolescent; Adult; Aged; Autoantibodies - blood; Biomedical and Life Sciences; Biomedicine; Brain research; Cohort Studies; Development and progression; Drug therapy; Female; Humans; Immunology; Immunosuppressive agents; Immunosuppressive Agents - therapeutic use; Immunotherapy; Life Sciences; Male; Middle Aged; MOG antibodies; Multiple sclerosis; Multiple Sclerosis, Relapsing-Remitting - blood; Multiple Sclerosis, Relapsing-Remitting - diagnosis; Multiple Sclerosis, Relapsing-Remitting - drug therapy; Myelin-Oligodendrocyte Glycoprotein - blood; Nervous system diseases; Neurobiology; Neurology; Neuromyelitis optica; Neuromyelitis Optica - blood; Neuromyelitis Optica - diagnosis; Neuromyelitis Optica - drug therapy; Neurons and Cognition; Neurosciences; Patient outcomes; Propensity score; Retrospective Studies; Rituximab - therapeutic use; Santé publique et épidémiologie; Treatment Outcome; Treatment response; Young Adult; France; Multiple sclerosis; Treatment response; Neuromyelitis optica; Propensity score; MOG antibodies